comprehensive -WSS

comprehensive

author：leisure time 2025-08-11 05:32:38 - browse：583

Portrait of Suhas Gondi. -- health coverage from STAT — Suhas Gondi of Brigham and Women's Hospital has researched and written about hospital boards increasingly being made up of private equity executives and others from outside medicine. Jonathan Wiggs/Globe Staff

Discontent among Mass General Brigham doctors had been at a slow burn for years. But when an unexpected announcement from the chief executive titled “A message about our future” popped into inboxes one morning last month, that frustration seemed to fully ignite.

Mass General Brigham, a dominant force in Boston medicine, was launching the latest and perhaps most contentious step in its ongoing effort to merge its two flagship Harvard-affiliated medical centers: combine all departments and divisions at both hospitals in a move that executives argued would improve patient care and access.

But after years of feeling shut out of decisions amid grinding work schedules, many doctors worried the changes would lead to layoffs, demotions, and an even greater loss of autonomy. During an online ‘‘town hall’’ on April 4, they inundated leaders with skeptical questions. One physician asked how executives planned to build trust with faculty when so many felt “unheard, devalued, disempowered, and unseen.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Adam's Biotech Scorecard: Do Sarepta's exon

WSS

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Report: NIH

David Sabatini, ex

Latest bird flu infection made farmworker sicker than earlier cases

FDA clears AI tool for detecting skin cancer

Average age of first period drops to 11.9 years, study shows

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Bright Health sells Medicare Advantage business to Molina

Test for long Covid? Researchers find new clue in blood samples

Cancer drug shortages should be causing more outrage

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Psychedelics group wrestles with new pharma identity

My yearlong odyssey to get my son’s ADHD medication covered

Hollywood unions extend contract negotiations for actors

Humana cuts profit projections as Medicare Advantage costs soar

Sports medicine is finally prioritizing gender equality

Childbirth

leisure time

AI used to predict Covid

Report: NIH

Insmed lung disease drug hits target in key Phase 3 trial

Scientists successfully use ultrasound imaging to map brain activity

Startling documents reveal new facets of Sacklers' opioid empire

AI generated plenty of interest at JPM but not a lot of trust

focus

explore

hotspot

focus